| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9712 | DOTA-NOC acetate |
9712.0001: 1 mg per vial 9712.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Precursor for radiolabelled DOTA-NOC
Ligand for somatostatin receptors |
||
| Molar Mass: 1455.7 | ||
| C69H94N14O17S2 | ||
| [619300-53-7] (net peptide) | ||
| Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 95 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: CA index name: L-Cysteinamide, N-[[4,7,10-tris(carboxymethyl)-1,4,7,10-tetraazacyclododec-1-yl]acetyl]-D-phenylalanyl-L-cysteinyl-3-(1-naphthalenyl)- L-alanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide |
||
|
Synonymes: DOTA-[Nal3]-octreotide |
||
|
Literature: 1. Wild D. et al. 68Ga-DOTANOC: a first compound for PET imaging with high affinity for somatostatin receptor subtypes 2 and 5. Eur.J. Nucl. Med. Mol. Imaging 2005, 32, 724. |
||
| 2. Wild D. et al. DOTA-NOC, a high-affinity ligand of somatostatin receptor subtypes 2, 3 and 5 for labeling with various radiometals. Eur. J. Nucl. Med. Mol. Imaging 2003, 30, 1338-1347. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1